A University of Virginia researcher has received a five-year, $2.1 million National Institutes of Health grant to develop ...
A research team has developed a stronger form of stem cell-derived extracellular vesicles that helps diabetic wounds rebuild ...
GOOSE produces blueprints for custom-built disordered proteins that are then created in genetically engineered cells.
Diabetes does not stop at elevated blood sugar, rather it often arrives with abnormal cholesterol, excess blood fats, and damage linked to oxidative stress. Together, those problems can raise the ...
CAP accreditation for CLIA is a recognized benchmark for laboratory excellence, following a comprehensive inspection of practices, systems, and personnel. This accreditation authorizes testing on ...
Would you try an anti-aging injectable made from donated human skin? Here’s what experts say about the science, safety and early results.
Specialized cells in the human body make biological trade-offs to perform certain jobs. To support the large, hardworking hearts that power other organs, heart cells have evolved to be extremely ...
Imperial College London and the University of Manchester researchers say they have used genome mining and an enzyme-based approach to reshape polyene bioactivity.
Durham-based Humacyte, a regenerative medicine company, will soon begin a first-in-human clinical study of its bioengineered blood vessel in patients undergoing coronary artery bypass grafting (CABG).
Durham-based SelSym Biotech, a biomedical company with roots at North Carolina State University, has secured an equity investor and partner to help it develop a novel therapy to control emergency ...
Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer ...